Systemic lupus erythematosus (SLE) is a chronic autoimmune disease in which the immune system attacks healthy tissues. Unlike many forms of arthritis, lupus can affect multiple organs, including the joints, skin, hair, kidneys, heart, lungs and brain. Because lupus is variable in presentation and severity, early diagnosis and ongoing rheumatology supervision are essential.
Common Symptoms of Lupus
Lupus may present with fatigue, joint pain or swelling, photosensitive skin rashes, hair thinning or loss, mouth ulcers and low blood counts. Many patients also experience Raynaud’s phenomenon — colour changes of the fingers in response to cold or stress (white → blue → red), sometimes associated with numbness or pain.
Cardiovascular Risk in Lupus
Lupus is associated with increased cardiovascular risk. Chronic inflammation, immune activation and steroid exposure contribute to accelerated atherosclerosis, coronary artery disease, stroke and hypertension. Even young patients may have elevated cardiovascular risk. Disease control, blood pressure monitoring, lipid management and lifestyle optimisation are therefore essential components of care.
Renal Involvement (Lupus Nephritis)
Kidney involvement is one of the most significant complications of lupus. It may present with protein in the urine, blood in the urine, swelling of the legs or raised blood pressure. In early stages, lupus nephritis can be silent. Regular urine and blood testing allows early detection and timely immunosuppressive treatment, significantly improving long-term kidney outcomes.
Sun Sensitivity & Skin Protection
Photosensitivity is common in lupus. Ultraviolet exposure can trigger skin flares and even systemic disease activity. Patients are advised to use broad-spectrum SPF 50 sunscreen daily, avoid excessive sun exposure and wear protective clothing. Consistent sun protection reduces flare risk.
Treatment of Lupus
Treatment depends on which organs are affected. Hydroxychloroquine is recommended for most patients — it reduces flares, protects organs and improves long-term outcomes. For more active disease, additional medicines such as methotrexate, azathioprine or mycophenolate may be required. For kidney, blood or resistant disease, belimumab or rituximab may be considered. Steroids are used for short-term control but carefully reduced to minimise long-term risks.
Lupus, Pregnancy and Antiphospholipid Syndrome
Most women with lupus can have successful pregnancies with careful planning. However, active disease increases pregnancy risk, and antiphospholipid antibodies (APS) may increase the risk of miscarriage or thrombosis. Pre-pregnancy counselling and coordinated care with rheumatology and obstetric specialists are important.
When to Seek Urgent Review
Seek prompt medical assessment if you develop discolouration or white fingers and toes, facial skin rash, significant worsening fatigue or joint swelling, new chest pain or shortness of breath, leg swelling, reduced urine output, or severe headache or neurological symptoms.
Frequently Asked Questions
Does lupus always affect the kidneys?
No, but kidney involvement can occur silently. Regular urine testing is essential for all lupus patients.
Is hydroxychloroquine safe long term?
Yes, when monitored appropriately (including periodic eye screening), it is safe and strongly recommended in most patients.
Can lupus increase heart risk?
Yes. Lupus increases cardiovascular risk significantly, making inflammation control and risk factor monitoring essential parts of management.
Can women with lupus have children?
Yes, with careful planning and specialist supervision. Stable disease before conception improves outcomes considerably.
What is antiphospholipid syndrome?
APS is an autoimmune condition associated with blood clotting risk and pregnancy complications. It may coexist with lupus and requires specific management.
